Kiyomi Morita^1,2, Feng Wang³, Katharina Jahn⁴, Yuanqing Yan⁵, Robert Durruthy-Durruthy⁶, Anup Parikh⁶, Jairo Matthews², Latasha Little³, Curtis Gumbs³, Jianhua Zhang³, Xingzhi Song³, Erika Thompson⁷, Keyur Patel⁸, Carlos Bueso-Ramos⁸, Courtney Dinardo², Farhad Ravandi², Elias Jabbour², Michael Andreeff², Jorge Cortes², Marina Konopleva², Guillermo Garcia-Manero², Hagop Kantarjian², Dennis Eastburn⁶, P Andrew Futreal³, Niko Beerenwinkel⁴, Koichi Takahashi² (1.Department of Hematology and Oncology, The University of Tokyo, 2.Department of Leukemia, MD Anderson Cancer Center, 3.Department of Genomic Medicine, MD Anderson Cancer Center, 4.Swiss Federal Institute of Technology in Zurich, 5.The University of Texas Health Science Center at Houston, 6.Mission Bio, Inc., 7.Department of Genetics, MD Anderson Cancer Center, Houston, 8.Department of Hematopathology, MD Anderson Cancer Center, Houston)

Yang Zhang¹, Fang Wang¹, Xue Chen¹, Yu Zhang¹, Mingyu Wang¹, Hong Liu¹, Panxiang Cao¹, Xiaoli Ma¹, Xian Zhang¹, Peihua Lu^1,2, Hongxing Liu^1,2 (1.Pathology & Laboratory Medicine Division, Hebei Yanda Lu Daopei Hospital, Langfang, Hebei, People's Republic of China, 2.Beijing Lu Daopei Institute of Hematology, Beijing, Beijing, People's Republic of China)

Ryosaku Inagaki^1,2,3, Masahiro Nakagawa^1,2, Yasuhito Nanya¹, Xingxing Qi¹, Lanying Zhao¹, June Takeda¹, Akinori Yoda¹, Ayana Kon¹, Hisashi Tsurumi⁴, Hideki Makishima¹, Seishi Ogawa^1,5,6 (1.Department of Pathology and Tumor Biology, Kyoto Univ., Kyoto, Japan, 2.DSK Project, Medical Innovation Center, Kyoto University, Kyoto, Japan, 3.Sumitomo Dainippon Pharma Co., Ltd., Osaka, Japan, 4.Department of Hematology, Gifu Univ., Gifu, Japan, 5.WPI-ASHBi, Kyoto Univ., Kyoto, Japan, 6.Centre for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden)

Jo Ishizawa¹, Sarah Zarabi^2,3, Eric Davis⁴, Ondrej Halgas^2,5, Takenobu Nii¹, Yulia Jitkova², Ran Zhao¹, Jonathan Stgermain², Lauren Heese¹, Grace Egan², Vivian Ruvolo¹, Samir Barghout^2,3, Yuki Nishida¹, Rose Hurren², Marcela Gronda², Todd Link⁶, Keith Wong⁵, Mark Mabanglo⁵, Kensuke Kojima^1,7, Gautam Borthakur¹, Neil Maclean², Mark Minden^2,3, Walid Houry^5,8, Hagop Kantarjian¹, Martin Stogniew⁹, Brian Raught^2,3, Emil Pai^2,3,5,10, Aaron Schimmer^2,3, Michael Andreeff¹ (1.Dept. of Leukemia, UT MD Anderson, Houston, USA, 2.Princess Margaret Cancer Centre, Toronto, Canada, 3.Dept. Med Biophysics, University of Toronto, Toronto, Canada, 4.Dept. of Leukemia, UT MD Anderson, Houston, USA, 5.Dept. of Biochemistry, University of Toronto, Toronto, Canada, 6.Dept. Genomic Medicine, Houston, USA, 7.Div. Hematorology, Respiratory Medicine, Oncology, Dept. Internal Medicine, Saga, Japan, 8.Dept. Chemistry, University of Toronto, Toronto, Canada, 9.Oncoceutics, Inc., Philadelphia, USA, 10.Dept. Molecular Genetics, University of Toronto, Toronto, Canada)

Yuichiro Semba^1,2, Takuji Yamauchi^1,2, Fumihiko Nakao¹, Qiuming Yao³, Junpei Nogami¹, Matthew Canver³, Luca Pinello⁴, Daniel Bauer³, Koichi Akashi^1,2, Takahiro Maeda^1,2 (1.Dep. of Med. and Biosystem. Sci., Kyushu Univ., Fukuoka, Japan, 2.Cell. and Mol. Med., Kyushu Univ. Hosp., Fukuoka, Japan, 3.Hemato. Onco., Boston Child. Hosp., Harvard Med. Sch, Boston, USA, 4.Cent. for Cancer Res., Massachusetts Gen. Hosp., Charlestown, USA)

Masayuki Kanda¹, Satoshi Wakita¹, Haruka Arai¹, Yuho Najima², Kensuke Usuki³, Toshimitsu Ueki⁴, Iekuni Oh⁵, Shinichiro Mori⁶, Nobuhiko Uoshima⁷, Yutaka Kobayashi⁷, Shinichi Kako⁸, Kenji Tajika⁹, Katsuhiro Shono¹⁰, Kensuke Kayamori¹¹, Masao Hagihara¹², Junya Kanda¹³, Hitoji Uchiyama¹⁴, Junya Kuroda¹⁵, Naoyuki Uchida¹⁶, Yasushi Kubota¹⁷, Shinya Kimura¹⁷, Saiko Kurosawa¹⁸, Nana Nakajima¹, Masahiro Sakaguchi¹, Kazuhiko Kakihana², Yoshinobu Kanda^5,9, Kazuteru Ohashi², Takahiro Fukuda¹⁸, Hiroki Yamaguchi¹, Koichi Inokuchi¹ (1.Department of Hematology, Nippon Medical School, Tokyo, Japan, 2.Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan, 3.Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan, 4.Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan, 5.Division of Hematology, Jichi Medical University, Tochigi, Japan, 6.Hemato-Oncology Department, St Lukes International Hospital, Tokyo, Japan, 7.Department of Hematology, Japanese Red Cross KyotoDaini Hospital, Kyoto, Japan, 8.Hematology Division, Saitama Medical Center, Jichi Medical University, Saitama, Japan, 9.Department of Hematology, Yokohama Minami Kyousai Hospital, Kanagawa, Japan, 10.Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan, 11.Department of Hematology, Chiba University Hospital, Chiba, Japan, 12.Department of Hematology, Eiju General Hopital, Tokyo, Japan, 13.Department of Hematology and Oncology, Kyoto University, Kyoto, Japan, 14.Hematology Division, Japanese Red-Cross Kyoto Daiichi Hospital, Kyoto, Japan, 15.Division of Hematology-and-Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 16.Department of Hematology, Toranomon Hospital, Tokyo, Japan, 17.Division of Hematology, Respiratory and Oncology, Saga University, Saga, Japan, 18.Department of HSCT, National Cancer Center Hospital, Tokyo, Japan)